Social Media Monitoring und Social Response Management

Umfassende Lösungen für regulatorische Anforderungen im Bereich Social Media.

Erfahrungen und Kompetenzen im Bereich Community Management

Webinar icon

Maßgeschneiderte Community-Management-Services

Dienstleistungen, die individuell auf Ihre Bedürfnisse zugeschnitten sind.

Maßgeschneiderte Community-Management-Services

Dienstleistungen, die individuell auf Ihre Bedürfnisse zugeschnitten sind.

Weniger lesen
Around the world icon

Multilinguale Services

35+ Sprachen

Multilinguale Services

35+ Sprachen

Weniger lesen
Authority Meetings icon

Hochqualifizierte Expert*innen

Unser Team ist auf AE‑ und PQC‑Berichterstattung spezialisiert und steht für exzellenten Service.

Hochqualifizierte Expert*innen

Unser Team ist auf AE‑ und PQC‑Berichterstattung spezialisiert und steht für exzellenten Service.

Weniger lesen
Global icon

Globales Serviceangebot

Wir bieten Erfahrungen mit Community-Management-Services auf der ganzen Welt unter Einhaltung der Vorschriften verschiedener Aufsichtsbehörden.

Globales Serviceangebot

Wir bieten Erfahrungen mit Community-Management-Services auf der ganzen Welt unter Einhaltung der Vorschriften verschiedener Aufsichtsbehörden.

Weniger lesen
Social media icon

Kompetenzen mit verschiedenen Plattformen

Facebook, Instagram, LinkedIn, X und mehr.

Kompetenzen mit verschiedenen Plattformen

Facebook, Instagram, LinkedIn, X und mehr.

Weniger lesen

Social Media Monitoring Services

ProPharma überwacht sorgfältig die Social-Media-Kanäle unserer Kund*innen und achtet dabei auf auftretende unerwünschte Ereignisse oder Produktbeschwerden. Sobald wir etwas Meldepflichtiges entdecken, dokumentieren wir es umgehend und melden es innerhalb der vorgeschriebenen Frist, um sicherzustellen, dass keine wichtigen Informationen verloren gehen.

Social Response Management

ProPharma geht aktiv auf Kommentare und Anfragen von Verbrauchern auf verschiedenen Social-Media-Plattformen ein und agiert dabei in Ihrem Namen. Wir verwenden von Kund*innen genehmigte standardisierte Antworten, die speziell auf diese Interaktionen zugeschnitten sind. Ob wir öffentlich auf Kommentare unter Beiträgen oder privat über Direktnachrichten antworten, ProPharma stellt sicher, dass jede Interaktion professionell, angemessen und nicht werblich ist. Mit diesem Service entfernt ProPharma auch unangemessene Kommentare aus Ihren Beiträgen, um das professionelle Image Ihres Unternehmens zu wahren.

Business professionals smiling at a desk reviewing data
Gradient Image

Kontaktieren Sie uns zu unserer Expertise im Bereich Community-Management Service

Wir haben es uns zur Aufgabe gemacht, die Gesundheit und das Wohlbefinden der Verbraucherinnen durch umfassendes Community-Management zu verbessern. Ganz gleich, ob Sie zuverlässige Social-Media-Monitoring-Dienstleistungen oder einen Komplettservice einschließlich Social Response Management benötigen, unser Expert*innenteam steht Ihnen gerne zur Verfügung.

News & Insights

Regulatory Readiness as a Strategic Advantage in European Study Start-Up

Juli 6, 2026

Regulatory Readiness as a Strategic Advantage in European Study Start-Up

Discover how regulatory readiness has evolved into a strategic advantage for clinical study start-ups in Europe, impacting timelines and operational efficiency.

Successful Tech Transfers Require Both Strong Regulatory Strategy and Execution

Juli 2, 2026

Successful Tech Transfers Require Both Strong Regulatory Strategy and Execution

Learn why successful tech transfers depend on early CMC strategy, comparability planning, and regulatory readiness—not just flawless execution.

Responsible AI in Medical Information: Safety, Ownership, Oversight

Juni 29, 2026

Responsible AI in Medical Information: Safety, Ownership, Oversight

Explore the critical role of responsible AI in medical information, focusing on safety, data ownership, and oversight to enhance patient care and trust.ca

ProPharma Advances Technology Enablement Strategy with AI-Assisted Capability for ANDA Submission Development

Juli 8, 2026

ProPharma Advances Technology Enablement Strategy with AI-Assisted Capability fo...

ProPharma unveils an AI-assisted capability to enhance ANDA submission development, improving efficiency and maintaining regulatory excellence for clients.

ProPharma Welcomes Kevin van Dooren to Strengthen Integrated EU Regulatory and HTA Capabilities

Juni 18, 2026

ProPharma Welcomes Kevin van Dooren to Strengthen Integrated EU Regulatory and H...

ProPharma welcomes Kevin van Dooren as Vice President, HEOR and Market Access, strengthening integrated EU regulatory, HTA, reimbursement, and market access capabilities for life sciences companies.

ProPharma Appoints Adrian Pencak as Chief Commercial Officer

Mai 27, 2026

ProPharma Appoints Adrian Pencak as Chief Commercial Officer

ProPharma announces Adrian Pencak as Chief Commercial Officer, bringing 25 years of leadership experience to enhance global commercial capabilities and client partnerships.

ProPharma Recognized for AI Excellence at ECCCSA

Januar 31, 2025

ProPharma Recognized for AI Excellence at ECCCSA

ProPharma wins Silver at ECCCSA for AI innovation in Medical Information, enhancing efficiency and quality in delivering accurate medical information.

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

Oktober 9, 2024

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

ProPharma wins CPHI Pharma Award for excellence in regulatory and compliance innovation, enhancing efficiency and accelerating market access for life-saving therapies.

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

September 24, 2024

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

ProPharma honored with Clinical Trials Excellence Award 2024, recognizing their outstanding contributions in the pharmaceutical industry.

Case Study Meeting Patients Where They Are: Delivering Global Clinical Support for Time-Sensitive Research - ProPharma

Juni 17, 2026

Meeting Patients Where They Are: Delivering Global Clinical Support for Time-Sen...

Conducting clinical research for rare pediatric populations presents unique operational challenges, particularly when eligible patients may be born anywhere in the world and require immediate...

Case Study Accelerating Commercial Readiness for a Novel Cell Therapy Program - ProPharma

Juni 10, 2026

Accelerating Commercial Readiness for a Novel Cell Therapy Program

As advanced therapy developers move from research-stage operations toward commercialization, they often face significant challenges in scaling quality systems, aligning regulatory strategy, and...

Case Study Keeping Research Moving Under Pressure: Delivering Data Integrity at Speed

Mai 20, 2026

Keeping Research Moving Under Pressure: Delivering Data Integrity at Speed

When patient enrollment rapidly exceeds expectations, clinical trials can face significant operational strain, putting data integrity, timelines, and critical sponsor decisions at risk. A mid-size...

Tech Meets Touch: Evaluating Empathy and AI in Medical Information Delivery

Juni 4, 2026

Tech Meets Touch: Evaluating Empathy and AI in Medical Information Delivery

Artificial intelligence (AI) is a hot topic in Medical Information (MI), yet real-world evidence of its impact in regulated, human-led MI environments remains limited. Hear practical, evidence-based...

Foundations of a Compliant EU–UK GMP–GDP Supply Chain: From Importation to Distribution

Juni 2, 2026

Foundations of a Compliant EU–UK GMP–GDP Supply Chain: From Importation to Distribution

A compliant and efficient EU–UK GMP–GDP supply chain requires a clear understanding of roles, responsibilities, and operational integration across importation, certification, and distribution...

Clinical Promise to Commercial Reality: The Path to Cell & Gene Therapy Market

April 23, 2026

Clinical Promise to Commercial Reality: The Path to Cell & Gene Therapy Market

As cell and gene therapies transition from clinical development to commercialization, organizations face evolving regulatory expectations, expanded CMC requirements, and increased MAH...

News & Insights

Regulatory Readiness as a Strategic Advantage in European Study Start-Up

July 6, 2026

Regulatory Readiness as a Strategic Advantage in European Study Start-Up

Discover how regulatory readiness has evolved into a strategic advantage for clinical study start-ups in Europe, impacting timelines and operational efficiency.

Successful Tech Transfers Require Both Strong Regulatory Strategy and Execution

July 2, 2026

Successful Tech Transfers Require Both Strong Regulatory Strategy and Execution

Learn why successful tech transfers depend on early CMC strategy, comparability planning, and regulatory readiness—not just flawless execution.

Responsible AI in Medical Information: Safety, Ownership, Oversight

June 29, 2026

Responsible AI in Medical Information: Safety, Ownership, Oversight

Explore the critical role of responsible AI in medical information, focusing on safety, data ownership, and oversight to enhance patient care and trust.ca

Previous Post Arrow Next Post Arrow
ProPharma Advances Technology Enablement Strategy with AI-Assisted Capability for ANDA Submission Development

July 8, 2026

ProPharma Advances Technology Enablement Strategy with AI-Assisted Capability fo...

ProPharma unveils an AI-assisted capability to enhance ANDA submission development, improving efficiency and maintaining regulatory excellence for clients.

ProPharma Welcomes Kevin van Dooren to Strengthen Integrated EU Regulatory and HTA Capabilities

June 18, 2026

ProPharma Welcomes Kevin van Dooren to Strengthen Integrated EU Regulatory and H...

ProPharma welcomes Kevin van Dooren as Vice President, HEOR and Market Access, strengthening integrated EU regulatory, HTA, reimbursement, and market access capabilities for life sciences companies.

ProPharma Appoints Adrian Pencak as Chief Commercial Officer

May 27, 2026

ProPharma Appoints Adrian Pencak as Chief Commercial Officer

ProPharma announces Adrian Pencak as Chief Commercial Officer, bringing 25 years of leadership experience to enhance global commercial capabilities and client partnerships.

Previous Post Arrow Next Post Arrow
ProPharma Recognized for AI Excellence at ECCCSA

January 31, 2025

ProPharma Recognized for AI Excellence at ECCCSA

ProPharma wins Silver at ECCCSA for AI innovation in Medical Information, enhancing efficiency and quality in delivering accurate medical information.

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

October 9, 2024

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

ProPharma wins CPHI Pharma Award for excellence in regulatory and compliance innovation, enhancing efficiency and accelerating market access for life-saving therapies.

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

September 24, 2024

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

ProPharma honored with Clinical Trials Excellence Award 2024, recognizing their outstanding contributions in the pharmaceutical industry.

Previous Award Arrow Next Award Arrow
Case Study Meeting Patients Where They Are: Delivering Global Clinical Support for Time-Sensitive Research - ProPharma

Juni 17, 2026

Meeting Patients Where They Are: Delivering Global Clinical Support for Time-Sen...

Conducting clinical research for rare pediatric populations presents unique operational challenges, particularly when eligible patients may be born anywhere in the world and require immediate...

Case Study Accelerating Commercial Readiness for a Novel Cell Therapy Program - ProPharma

Juni 10, 2026

Accelerating Commercial Readiness for a Novel Cell Therapy Program

As advanced therapy developers move from research-stage operations toward commercialization, they often face significant challenges in scaling quality systems, aligning regulatory strategy, and...

Case Study Keeping Research Moving Under Pressure: Delivering Data Integrity at Speed

Mai 20, 2026

Keeping Research Moving Under Pressure: Delivering Data Integrity at Speed

When patient enrollment rapidly exceeds expectations, clinical trials can face significant operational strain, putting data integrity, timelines, and critical sponsor decisions at risk. A mid-size...

Previous Resource Arrow Next Resource Arrow
Tech Meets Touch: Evaluating Empathy and AI in Medical Information Delivery

Juni 4, 2026

Tech Meets Touch: Evaluating Empathy and AI in Medical Information Delivery

Artificial intelligence (AI) is a hot topic in Medical Information (MI), yet real-world evidence of its impact in regulated, human-led MI environments remains limited. Hear practical, evidence-based...

Foundations of a Compliant EU–UK GMP–GDP Supply Chain: From Importation to Distribution

Juni 2, 2026

Foundations of a Compliant EU–UK GMP–GDP Supply Chain: From Importation to Distribution

A compliant and efficient EU–UK GMP–GDP supply chain requires a clear understanding of roles, responsibilities, and operational integration across importation, certification, and distribution...

Clinical Promise to Commercial Reality: The Path to Cell & Gene Therapy Market

April 23, 2026

Clinical Promise to Commercial Reality: The Path to Cell & Gene Therapy Market

As cell and gene therapies transition from clinical development to commercialization, organizations face evolving regulatory expectations, expanded CMC requirements, and increased MAH...

Previous Webinar Arrow Next Webinar Arrow